InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 11/02/2012

Re: None

Wednesday, 09/09/2020 3:47:01 PM

Wednesday, September 09, 2020 3:47:01 PM

Post# of 1232
Based on the actual fundamentals, I do believe that VSQTF is undervalued. And I mean before whatever expected revenues from their COVID 19 test kit sales.

On Sept 1st they reported net income of $.07/share. https://www.marketwatch.com/press-release/victory-square-technologies-reports-a-record-first-half-2020-2020-09-01-61841047?siteid=bigcharts&dist=bigcharts&tesla=y. At a current price of $.43/share, VSQTF it is trading @ a P/E Ratio = 6. That is low by any "normal" standards (usually revenue producing companies tend to historically trade around P/E Ratio = 10). Therefore, a $.70/share would be the "norm".

And please keep in mind this is RIGHT NOW, without COVID 19 kits sales being factored in,... Assuming only "few $ millions" income from COVID 19 kits sales we could logically predict a price of $3-4/share, at the lower end.

Not a pitch for others to buy VSQTF. Just my 2 cents :)